apoD Inhibitors
The class of apoD inhibitors comprises a diverse array of compounds that intricately modulate apoD through both direct and indirect mechanisms. As delineated in the tabulated form, these inhibitors offer a nuanced approach, targeting various cellular pathways to finely tune the expression of apoD. A compelling illustration of indirect inhibition is found in Ketoconazole, a compound that disrupts the steroid biosynthesis pathway. By inhibiting cytochrome P450, Ketoconazole curtails the production of steroid hormones, thereby influencing the expression of apoD. Similarly, Simvastatin operates indirectly by perturbing the mevalonate pathway, impacting isoprenoid synthesis and signaling molecules associated with the regulation of apoD.
Moving beyond indirect modulation, compounds like SB431542 and U0126 act on the TGF-β and MAPK/ERK pathways, respectively. These interactions cascade into downstream effects that intricately impact the expression of apoD. The inclusion of these compounds in the inhibitor repertoire highlights the sophisticated interplay between signaling cascades and the regulation of apoD. This comprehensive understanding of the inhibitors, coupled with their specific biochemical actions, not only sheds light on the modulation of apoD but also offers valuable insights into the implications of apoD in various cellular processes. In conclusion, the diverse range of inhibitors, each with its distinct mode of action, underscores the intricate nature of apoD regulation. This nuanced understanding paves the way for exploring the multifaceted roles of apoD in cellular processes and opens avenues for further research.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Ketoconazole | 65277-42-1 | sc-200496 sc-200496A | 50 mg 500 mg | $63.00 $265.00 | 21 | |
Ketoconazole inhibits apoD indirectly by modulating the steroid biosynthesis pathway. It targets cytochrome P450, reducing the production of steroid hormones that can influence apoD expression. | ||||||
Simvastatin | 79902-63-9 | sc-200829 sc-200829A sc-200829B sc-200829C | 50 mg 250 mg 1 g 5 g | $31.00 $89.00 $135.00 $443.00 | 13 | |
Simvastatin acts as an indirect inhibitor of apoD by targeting the mevalonate pathway. By inhibiting HMG-CoA reductase, it reduces the synthesis of isoprenoids, impacting signaling molecules that may affect apoD levels. | ||||||
GW 9662 | 22978-25-2 | sc-202641 | 5 mg | $70.00 | 30 | |
GW9662 is a PPARγ antagonist that indirectly influences apoD expression. It suppresses PPARγ, a nuclear receptor involved in lipid metabolism, leading to alterations in lipid signaling pathways that can modulate apoD. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $82.00 $216.00 $416.00 | 48 | |
SB431542 is a TGF-β receptor inhibitor that indirectly affects apoD. By blocking TGF-β signaling, it disrupts downstream pathways involved in apoD regulation, altering cellular responses related to lipid metabolism. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin, a PI3-kinase inhibitor, indirectly modulates apoD expression by affecting the PI3K/Akt signaling pathway. It disrupts intracellular signaling cascades, leading to changes in cellular processes that impact apoD levels. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin, an mTOR inhibitor, indirectly modulates apoD by influencing the mTOR signaling pathway. It disrupts protein synthesis and cellular responses, leading to alterations in pathways that regulate apoD expression. | ||||||
Tyrphostin AG 1478 | 175178-82-2 | sc-200613 sc-200613A | 5 mg 25 mg | $96.00 $421.00 | 16 | |
AG1478 is an EGFR inhibitor that indirectly affects apoD expression. By targeting EGFR, it disrupts downstream signaling pathways, altering cellular responses involved in the regulation of apoD. | ||||||
BAY 11-7082 | 19542-67-7 | sc-200615B sc-200615 sc-200615A | 5 mg 10 mg 50 mg | $62.00 $85.00 $356.00 | 155 | |
BAY 11-7082 is an NF-κB inhibitor that indirectly influences apoD expression. It suppresses NF-κB activation, leading to changes in the transcriptional regulation of genes, including those related to apoD. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002, a PI3-kinase inhibitor, indirectly modulates apoD expression by affecting the PI3K/Akt pathway. It disrupts intracellular signaling cascades, leading to changes in cellular processes that impact apoD levels. | ||||||
Fluvastatin | 93957-54-1 | sc-279169 | 50 mg | $250.00 | ||
Fluvastatin acts as an indirect inhibitor of apoD by targeting the mevalonate pathway. By inhibiting HMG-CoA reductase, it reduces the synthesis of isoprenoids, impacting signaling molecules that may affect apoD levels. | ||||||